102 related articles for article (PubMed ID: 23395558)
21. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
22. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.
Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD
Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003
[TBL] [Abstract][Full Text] [Related]
23. STAR and AKR1B10 are down-regulated in high-grade endometrial cancer.
Sinreih M; Štupar S; Čemažar L; Verdenik I; Frković Grazio S; Smrkolj Š; Rižner TL
J Steroid Biochem Mol Biol; 2017 Jul; 171():43-53. PubMed ID: 28232277
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the sensitivity, specificity, positive and negative predictive values of preoperative magnetic resonance imaging for staging endometrial cancer. A prospective study of 100 cases at the Dorset Cancer Centre.
Ortashi O; Jain S; Emannuel O; Henry R; Wood A; Evans J
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):232-5. PubMed ID: 17537566
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological features including hormonal receptor expression and survival in young endometrial cancer patients: a case control study.
Tangjitgamol S; Manusirivithaya S; Srijaipracharoen S; Tanvanich S; Khunnarong J; Thavaramara T; Pataradool K; Leelahakorn S
Asian Pac J Cancer Prev; 2010; 11(6):1487-92. PubMed ID: 21338185
[TBL] [Abstract][Full Text] [Related]
26. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
[TBL] [Abstract][Full Text] [Related]
27. [Molecular based targets and endometrial cancer].
Stoyanov S; Ananiev J; Ivanova K; Velev V; Todorova M; Gulubova M
Akush Ginekol (Sofiia); 2015; 54(2):38-45. PubMed ID: 25909140
[TBL] [Abstract][Full Text] [Related]
28. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
29. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
30. [Immunohistochemical study of PCNA, p53 gene product and c-erbB-2 gene product in endometrial carcinoma].
Miyazaki M
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Apr; 48(4):269-76. PubMed ID: 8936111
[TBL] [Abstract][Full Text] [Related]
31. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.
Terashima M; Kitada K; Ochiai A; Ichikawa W; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M;
Clin Cancer Res; 2012 Nov; 18(21):5992-6000. PubMed ID: 22977193
[TBL] [Abstract][Full Text] [Related]
32. Triple negative endometrial cancer.
Bulsa M; Urasińska E
Ginekol Pol; 2017; 88(4):212-214. PubMed ID: 28509323
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
Koutras A; Kalogeras KT; Wirtz RM; Alexopoulou Z; Bobos M; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Pentheroudakis G; Pisanidis N; Magkou C; Christodoulou C; Bafaloukos D; Papakostas P; Aravantinos G; Pectasides D; Kalofonos HP; Fountzilas G
J Transl Med; 2015 May; 13():171. PubMed ID: 26021752
[TBL] [Abstract][Full Text] [Related]
34. Expression of keratinocyte growth factor receptor compared with that of epidermal growth factor receptor and erbB-2 in endometrial adenocarcinoma.
Visco V; Carico E; Marchese C; Torrisi MR; Frati L; Vecchione A; Muraro R
Int J Oncol; 1999 Sep; 15(3):431-5. PubMed ID: 10427121
[TBL] [Abstract][Full Text] [Related]
35. Significance of epidermal growth factor receptor expression in primary human endometrial cancer.
Scambia G; Benedetti Panici P; Ferrandina G; Battaglia F; Distefano M; D'Andrea G; De Vincenzo R; Maneschi F; Ranelletti FO; Mancuso S
Int J Cancer; 1994 Jan; 56(1):26-30. PubMed ID: 8262674
[TBL] [Abstract][Full Text] [Related]
36. Endometrial cancer in women 40 years old or younger.
Duska LR; Garrett A; Rueda BR; Haas J; Chang Y; Fuller AF
Gynecol Oncol; 2001 Nov; 83(2):388-93. PubMed ID: 11606102
[TBL] [Abstract][Full Text] [Related]
37. Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.
Giatromanolaki A; Koukourakis MI; O'Byrne K; Kaklamanis L; Dicoglou C; Trichia E; Whitehouse R; Harris AL; Gatter KC
Anticancer Res; 1996; 16(6B):3819-25. PubMed ID: 9042264
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology).
Mustea A; Koensgen D; Belau A; Sehouli J; Lichtenegger W; Schneidewind L; Sommer H; Markmann S; Scharf JP; Ehmke M; Ledwon P; Braicu I; Zygmunt M; Koehler G
Cancer Chemother Pharmacol; 2013 Nov; 72(5):975-83. PubMed ID: 23995698
[TBL] [Abstract][Full Text] [Related]
39. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
[TBL] [Abstract][Full Text] [Related]
40. Endometrial carcinoma: clinical characteristic and survival rates by the new compared to the prior FIGO staging systems.
Tangjitgamol S; Srijaipracharoen S; Manusirivithaya S; Khunnarong J; Pataradool K; Thavaramara T
J Med Assoc Thai; 2013 May; 96(5):505-12. PubMed ID: 23745302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
